House Health Policy Hears Testimony on Behavioral Health Transport Legislation

Legislation addressing behavioral health transport received testimony in the House Health Policy Committee during the week of June 15, while other key healthcare bills advanced in the legislature.

Kyle Hoffmaster, director of patient access, Pine Rest Christian Mental Health Services, testifies before the House Health Policy Committee in support of legislation establishing a licensure framework for behavioral health transportation services in Michigan.

House Bills (HB) 59435944, sponsored by Reps. Steve Frisbie (R-Battle Creek) and Amos O’Neal (D-Saginaw), received a hearing before the House Health Policy Committee. The bills would establish a licensure framework for behavioral health transportation services in Michigan and require Medicaid coverage for those services. Kyle Hoffmaster, director of patient access, Pine Rest Christian Mental Health Services, testified on behalf of hospitals and discussed how behavioral health transport services reduce patient wait times and provide a safe, secure alternative for transporting individuals experiencing a behavioral health crisis. Kelsey Ostergren, senior director, health policy, MHA, also testified before the committee and emphasized that the legislation would expand access to care, while generating significant Medicaid savings. The MHA looks forward to the House Health Policy Committee advancing this legislation.

The House Health Policy Committee also considered HBs 57285738, which would relieve hospitals of administratively burdensome and duplicative requirements for substance use disorder program licensure. The MHA supports this legislation. The committee also voted unanimously to advance several bipartisan bills addressing medical debt. HBs 52545255 and 60716073, along with Senate Bills (SB) 449451 and SBs 701702, are companion measures that would codify hospital financial assistance programs (FAPs), establish reporting requirements for FAP benefits and prohibit medical debt from being reported to credit bureaus. The legislation would also modify medical debt collection practices, including restrictions on the sale of medical debt and limits on interest charges. These bills have now been referred to the House floor for further consideration.

The House Rules Committee voted to advance HB 4864, sponsored by Rep. Julie Rogers (D-Kalamazoo), which would revise the definition of elevated blood lead levels for lead abatement purposes. The Senate Health Policy Committee also approved SB 1011, sponsored by Sen. Kevin Hertel (D-St. Clair Shores). The bill would create a small-business health pool, allowing employers with 500 or fewer employees to establish state-regulated multiple-employer welfare arrangements that provide health coverage for eligible employees and self-employed individuals.

Lastly, the Michigan Senate passed SBs 973978, led by Sen. Kevin Hertel (D-St. Clair Shores), which would create a state-based health insurance exchange in Michigan. The bills would allow the Department of Insurance and Financial Services to seek a federal waiver to establish the exchange and maintain contracts with participating health plans. The MHA supports HB 4864, SB 1011 and SBs 973-977.

Members with questions may contact the MHA advocacy team.

HHS Announces $100M Investment in Substance Use and Mental Health Treatment

U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced a $100 million investment to expand substance use disorder treatment, mental health services and housing-related supports under the administration’s Great American Recovery initiative.

The funding will launch the Safety Through Recovery, Engagement, and Evidence-based Treatment and Supports (STREETS) initiative, which will support targeted outreach, psychiatric care, medical stabilization, crisis intervention and connections to stable housing for individuals experiencing homelessness and substance use disorder.

HHS also announced a $10 million Assisted Outpatient Treatment (AOT) grant program to support adults who have difficulty engaging in traditional outpatient care. The program uses court-ordered, community-based treatment as an alternative to hospitalization, homelessness or involvement with the criminal justice system.

In addition, HHS announced changes allowing states and tribes to receive a 50% federal match to provide medications for opioid use disorder, buprenorphine, methadone and naltrexone, to parents whose children are at risk of entering foster care. The medications are approved by the U.S. Food and Drug Administration and are intended to support recovery and family stability.

Members with questions may contact Lenise Freeman at the MHA.